Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
- Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisActive Not Recruiting
Sponsor: Sanofi
Multiple Sclerosis
United States, Argentina, Austria, Belgium, Brazil +36 more
Sponsor: TG Therapeutics, Inc.
B-cell Mediated Autoimmune Disorders
United States
- Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Active Not Recruiting
Sponsor: Zura Bio Inc
Systemic Sclerosis (SSc) · Scleroderma
United States, Argentina, Chile, Hungary, Mexico +5 more
- A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast MilkRecruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
United States
- Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple SclerosisRecruiting
Sponsor: MGH Institute of Health Professions
Multiple Sclerosis
United States
Sponsor: Shionogi
Amyotrophic Lateral Sclerosis (ALS)
United States, Canada, France, Germany, Italy +1 more
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis · Multiple Sclerosis
United States, Puerto Rico
Sponsor: University of Alabama at Birmingham
Multiple Sclerosis, Relapsing-Remitting
United States
Sponsor: Hoffmann-La Roche
Progressive Multiple Sclerosis
Australia, France, Germany, Hungary, Italy +6 more
Sponsor: TG Therapeutics, Inc.
Multiple Sclerosis
Bosnia and Herzegovina, Georgia, North Macedonia, Poland, Serbia +1 more
- Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabRecruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
United States, Poland
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Multiple Sclerosis
United States
Sponsor: Johns Hopkins University
Multiple Sclerosis
United States
Sponsor: TG Therapeutics, Inc.
Multiple Sclerosis
United States
- An Extension Study of Ublituximab in Participants With Relapsing Multiple SclerosisActive Not Recruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis (RMS)
United States, Belarus, Croatia, Georgia, Poland +3 more
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
Poland
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Georgia +4 more
- Effects Of Motor Imagery and Sensorimotor TrainingNot Yet Recruiting
Sponsor: Uludag University
Multiple Sclerosis
Turkey (Türkiye)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Cystic Fibrosis · Pulmonary Fibrosis · Tuberous Sclerosis · Asthma
United States
Sponsor: Tiffany J. Braley, MD, MS
Multiple Sclerosis · Sleep · Pain
United States
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemRecruiting
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Central Nervous System Disease · Multiple Sclerosis
United States
Sponsor: Texas Woman's University
Multiple Sclerosis
United States
Sponsor: Janssen Research & Development, LLC
Relapsing Remitting Multiple Sclerosis
United States
- Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic ToolNot Yet Recruiting
Sponsor: King's College London
Optic Neuritis · Multiple Sclerosis · Neuromyelitis Optica Spectrum Disorder · Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders
United Kingdom
- A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple SclerosisActive Not Recruiting
Sponsor: Genentech, Inc.
Multiple Sclerosis
United States